Vanguard Group Inc Anebulo Pharmaceuticals, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
21Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$36.8 Million18.74% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$7.23 Million0.18% of portfolio
-
Mangrove Partners New York, NY2.53MShares$6.01 Million0.52% of portfolio
-
Morgan Stanley New York, NY399KShares$950,1410.0% of portfolio
-
Lvw Advisors, LLC350KShares$832,0880.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $61M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...